Treatment of Advanced Systemic Mastocytosis with Midostaurin: Practical Guidance for Optimal Therapy and Management.

"Competing interests: The authors declare no conflict of Interest.: Conflicts of Interest. CP reports to have participated in Advisory Boards for Novartis and AbbVie, outside the submitted work. LF has nothing to disclose. VF reports to have participated in an Advisory Board for Amgen, outside the submitted work. FIG has nothing to disclose. NP has nothing to disclose. PP reports payment or honoraria as a speaker and for Advisory Boards from Novartis Italia, outside the submitted work. AR reports consulting fees from Novartis and to have participated on a Data Safety Monitoring Board/Advisory Board for Novartis, outside the submitted work."

"The authors thank Patrick Moore, PhD for medical writing assistance on behalf of Health Publishing & Services srl, which was funded by Novartis Farma, Origgio, Italy in accordance with Good Publication Practice (GPP3) guidelines."